Advertisement

Topics

Opko Health (OPK) and Haemonetics (HAE) Financial Survey

22:03 EDT 25 Mar 2018 | Topix

Opko Health and Haemonetics are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Opko Health currently has a consensus price target of $12.10, suggesting a potential upside of 270.03%.

Original Article: Opko Health (OPK) and Haemonetics (HAE) Financial Survey

NEXT ARTICLE

More From BioPortfolio on "Opko Health (OPK) and Haemonetics (HAE) Financial Survey"

Advertisement
Quick Search
Advertisement
Advertisement